Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021
Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)
by more efficient management of pharmaceutical supplies. Administrative Expenses During 9M17, administrative expenses increased by 14% yoy due mainly to the increase of headcounts and salary rate in
subsidiaries had total revenue of 309.59 million Baht, increased by 128.60 million Baht, or an increase of 71.06%, compared with the same period of previous year. The Company and its subsidiaries had a net
the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital
revenue has continuously grown mainly due to its greater expansion of laboratory scopes of testing and analyzing for agricultural, food, and pharmaceutical associated with continual growing number of
OHTL Public Co., Ltd. and its subsidiaries Management Discussion and Analysis for Three-Month Period Ended 31 December 2017 (Unit: Thousand Baht) 2017 2016 Increased/(Decreased) % Occupancy 52.2
). Revenue has increased 1.26 million baht (ratio 2.45%) due to sale local increased by 0.96 million baht, increasing return estimates 0.46 million baht, rental income increased 0.54 million baht, other
% because of the follow main reasons. 1. Revenue from hospital operations increased by Baht 52.43 million or 8.94 % due to in Q3/2018 the revenue from general patient increased. 2. Cost of hospital operations